These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 32602800)

  • 21. Association of mitochondrial haplogroups H and R with keratoconus in Saudi Arabian patients.
    Abu-Amero KK; Azad TA; Sultan T; Kalantan H; Kondkar AA; Al-Muammar AM
    Invest Ophthalmol Vis Sci; 2014 May; 55(5):2827-31. PubMed ID: 24722698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The search of 'novel' mtDNA mutations in hypertrophic cardiomyopathy: MITOMAPping as a risk factor.
    Bandelt HJ; Yao YG; Salas A
    Int J Cardiol; 2008 Jun; 126(3):439-42. PubMed ID: 17482693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of anterior mitral valve leaflet length in individuals with a hypertrophic cardiomyopathy gene mutation without hypertrophic changes.
    van Velzen HG; Schinkel AFL; Menting ME; van den Bosch AE; Michels M
    J Ultrasound; 2018 Sep; 21(3):217-224. PubMed ID: 29876904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
    Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic basis of end-stage hypertrophic cardiomyopathy.
    Garcia-Pavia P; Vázquez ME; Segovia J; Salas C; Avellana P; Gómez-Bueno M; Vilches C; Gallardo ME; Garesse R; Molano J; Bornstein B; Alonso-Pulpon L
    Eur J Heart Fail; 2011 Nov; 13(11):1193-201. PubMed ID: 21896538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Right ventricular function in hypertrophic cardiomyopathy: A speckle tracking echocardiography study.
    Cincin A; Tigen K; Karaahmet T; Dündar C; Gürel E; Bulut M; Sünbül M; Başaran Y
    Anatol J Cardiol; 2015 Jul; 15(7):536-41. PubMed ID: 25537994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac symptoms before sudden cardiac death caused by hypertrophic cardiomyopathy: a nationwide study among the young in Denmark.
    Lynge TH; Risgaard B; Jabbari R; Glinge C; Bundgaard H; Maron B; Haunsø S; Winkel BG; Tfelt-Hansen J
    Europace; 2016 Dec; 18(12):1801-1808. PubMed ID: 26823388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study.
    Marian AJ; Tan Y; Li L; Chang J; Syrris P; Hessabi M; Rahbar MH; Willerson JT; Cheong BY; Liu CY; Kleiman NS; Bluemke DA; Nagueh SF
    Circ Res; 2018 Apr; 122(8):1109-1118. PubMed ID: 29540445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic basis and outcome in a nationwide study of Finnish patients with hypertrophic cardiomyopathy.
    Jääskeläinen P; Vangipurapu J; Raivo J; Kuulasmaa T; Heliö T; Aalto-Setälä K; Kaartinen M; Ilveskoski E; Vanninen S; Hämäläinen L; Melin J; Kokkonen J; Nieminen MS; ; Laakso M; Kuusisto J
    ESC Heart Fail; 2019 Apr; 6(2):436-445. PubMed ID: 30775854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrial natriuretic peptide gene polymorphism is not associated with hypertrophic cardiomyopathy.
    Xue H; Wang H; Wang XJ; Sun K; Wang SX; Song XD; Hui RT
    Chin Med J (Engl); 2010 Jan; 123(2):188-92. PubMed ID: 20137368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to letter to the editor "mitochondrial haplogroups are associated with hypertrophic cardiomyopathy in the Indian population".
    Govindaraj P; Khan NA; Rani B; Rani DS; Selvaraj P; Jyothi V; Bahl A; Narasimhan C; Rakshak D; Premkumar K; Khullar M; Thangaraj K
    Mitochondrion; 2015 Jan; 20():103-4. PubMed ID: 25110060
    [No Abstract]   [Full Text] [Related]  

  • 32. Mitochondrial Dysfunctions Contribute to Hypertrophic Cardiomyopathy in Patient iPSC-Derived Cardiomyocytes with MT-RNR2 Mutation.
    Li S; Pan H; Tan C; Sun Y; Song Y; Zhang X; Yang W; Wang X; Li D; Dai Y; Ma Q; Xu C; Zhu X; Kang L; Fu Y; Xu X; Shu J; Zhou N; Han F; Qin D; Huang W; Liu Z; Yan Q
    Stem Cell Reports; 2018 Mar; 10(3):808-821. PubMed ID: 29456182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between mitochondrial DNA haplogroup and myelodysplastic syndromes.
    Poynter JN; Richardson M; Langer E; Hooten AJ; Roesler M; Hirsch B; Nguyen PL; Cioc A; Warlick E; Ross JA
    Genes Chromosomes Cancer; 2016 Sep; 55(9):688-93. PubMed ID: 27121678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical features, outcomes and genetic characteristics of hypertrophic cardiomyopathy patients with severe right ventricular hypertrophy.
    Guo X; Fan C; Tian L; Liu Y; Wang H; Zhao S; Duan F; Zhang X; Zhao X; Wang F; Zhu H; Lin A; Wu X; Li Y
    PLoS One; 2017; 12(3):e0174118. PubMed ID: 28323875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic variation at the long noncoding RNA H19 gene is associated with the risk of hypertrophic cardiomyopathy.
    Gómez J; Lorca R; Reguero JR; Martín M; Morís C; Alonso B; Iglesias S; Díaz-Molina B; Avanzas P; Coto E
    Epigenomics; 2018 Jul; 10(7):865-873. PubMed ID: 29962225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of ApoE and protection from amyloid-beta toxicity in transmitochondrial cybrids with haplogroup K mtDNA.
    Thaker K; Chwa M; Atilano SR; Coskun P; Cáceres-Del-Carpio J; Udar N; Boyer DS; Jazwinski SM; Miceli MV; Nesburn AB; Kuppermann BD; Kenney MC
    Neurobiol Dis; 2016 Sep; 93():64-77. PubMed ID: 27109188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Association between aldosterone synthase gene polymorphism and hypertrophic cardiomyopathy].
    Chen AH; Zhang WX; Li ZL; Tang XM; Lu Q; Qian XX; Li LY; Sun JZ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Aug; 22(8):704-6. PubMed ID: 12376254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of Hypertrophic Cardiomyopathy Related Gene Mutations and Clinical Manifestations in Vietnamese Patients With Hypertrophic Cardiomyopathy.
    Tran Vu MT; Nguyen TV; Huynh NV; Nguyen Thai HT; Pham Nguyen V; Ho Huynh TD
    Circ J; 2019 Aug; 83(9):1908-1916. PubMed ID: 31308319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A heteroplasmic mitochondrial DNA 3310 mutation in the ND1 gene in a patient with type 2 diabetes, hypertrophic cardiomyopathy, and mental retardation.
    Hattori Y; Takeoka M; Nakajima K; Ehara T; Koyama M
    Exp Clin Endocrinol Diabetes; 2005 Jun; 113(6):318-23. PubMed ID: 15977098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A delta-sarcoglycan gene polymorphism as a risk factor for hypertrophic cardiomyopathy.
    Ordoñez-Razo RM; Garrido-Garduño MH; Pérez-Martínez RA; Ruiz VM; Herrera-Tepatlán E; Rodríguez-Cruz M; Jiménez-Vaca AL; Minauro-Sanmiguel F; Salamanca-Gómez FA
    Genet Test Mol Biomarkers; 2012 Aug; 16(8):855-8. PubMed ID: 22524166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.